Company news
Biomerica, Inc. news in 2022
Biomerica, Inc.'s news releases, calls and decks from 2022, newest first.
Biomerica Receives KFDA and Ministry of Health Approval for Colorectal Screening and Breast Screening Tests in Saudi Arabia and UAE
December 7, 2022
Biomerica’s Aware® Breast Self Exam and EZ Detect™ Colon Disease Test Now Available on Amazon and Fulfilled by Amazon
September 28, 2022
Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer
August 29, 2022
Biomerica Reports Fiscal 2022 Year End Results
August 28, 2022
Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™
May 11, 2022
Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population
April 25, 2022
Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021
April 13, 2022
Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patients with Irritable Bowel Syndrome
February 7, 2022
Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021
January 12, 2022
Decks in 2022
- Investor Presentation (November 2022)
Investor deck · 30 slides · Nov 14, 2022